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Abstract
Pyridine nucleotide transhydrogenases of bacterial cytosolic membranes and mitochondrial inner membranes are proton
pumps in which hydride transfer between NADP and NAD is coupled to proton translocation across cytosolic or
mitochondrial membranes. The pyridine nucleotide transhydrogenase of Escherichia coli is composed of two subunits (K and
L). Three domains are recognized. The extrinsic cytosolic domain 1 of the amino-terminal region of the K subunit bears the
NAD(H)-binding site. The NADP(H)-binding site is present in domain 3, the extrinsic cytosolic carboxyl-terminal region of
the L subunit. Domain 2 is composed of the membrane-intrinsic carboxyl-terminal region of the K subunit and the
membrane-intrinsic amino-terminal region of the L subunit. Treatment of the transhydrogenase of E. coli with 4-chloro-7-
nitrobenzo-2-oxa-1,3-diazole (NBD chloride) inhibited enzyme activity. Analysis of inhibition revealed that several sites on
the enzyme were involved. NBD chloride modified two (LCys-147 and LCys-260) of the seven cysteine residues present in the
transhydrogenase. Modification of LCys-260 in domain 2 resulted in inhibition of enzyme activity. Modification of residues
other than cysteine residues also resulted in inhibition of transhydrogenation as shown by use of a cysteine-free mutant
enzyme. The L subunit was modified by NBD chloride to a greater extent than the K subunit. Reaction of domain 2 and
domain 3 was prevented by NADPH. Modification of domain 3 is probably not associated with inhibition of enzyme
activity. Modification of domain 2 of the L subunit resulted in a decreased binding affinity for NADPH at its binding site in
domain 3. The product resulting from the reaction of NBD chloride with NADPH was a very effective inhibitor of
transhydrogenation. In experiments with NBD chloride in the presence of NADPH it is likely that all of the sites of reaction
described above will contribute to the inhibition observed. The NBD-NADPH adduct will likely be more useful than NBD
chloride in investigations of the pyridine nucleotide transhydrogenase. ß 1999 Elsevier Science B.V. All rights reserved.
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1. Introduction
Pyridine nucleotide transhydrogenase is a proton
pump which catalyzes the reversible reaction
Hout+NADP
+NADH 2 NADPH+NAD+Hin,
where reduction of NADP by NADH is linked to
an inward translocation of protons from the peri-
plasm (in bacteria) or cytosol (in mammalian cells)
into the cytosol or mitochondrial matrix, respec-
tively. The properties of transhydrogenases have
been reviewed recently [1^4].
The enzyme in Escherichia coli is composed of two
di¡erent subunits (K, 510 residues; L, 462 residues)
assembled as an K2L2 tetramer [5^8]. All membrane
transhydrogenases are organized into three domains
[1,9,10]. Domain 1 is a cytosolic domain which con-
tains the binding site for NAD(H) and is the amino-
terminal region of the K subunit. Domain 3 is a
cytosolic domain found at the carboxyl-terminal re-
gion of the L subunit. It contains the NADP(H)-
binding site. Domain 2 is the transmembranous re-
gion of the enzyme. It consists in E. coli of two
parts: the carboxyl-terminal region of the K subunit,
which terminates in four transmembrane K-helices,
and the eight or nine transmembrane K-helices which
compose the amino-terminal half of the L subunit.
Proton translocation across domain 2 is coupled to
hydride ion transfer between domains 1 and 3. The
driving force for proton translocation is likely the
di¡erence in binding energies between the substrates
and products of the reaction [1,11,12].
The reagent 4-chloro-7-nitrobenzo-2-oxa-1,3-diaz-
ole (NBD chloride) has been used as an enzyme in-
hibitor. Its use has been particularly informative in
studies of the mechanism of the F1-adenosine tri-
phosphatase [13^18]. NBD chloride reacts at pH
7.0 with thiols and with the phenolic hydroxyl group
of tyrosine. At higher pH values (8.0 and above) it
will react with amino groups. The NBD group can
also be transferred from tyrosine to lysine residues at
the higher pH [13^16,19]. Persson et al. [20] have
investigated the action of NBD chloride on the
beef-heart mitochondrial transhydrogenase. They
found that 4^6 cysteine residues of the 10 present
in the enzyme reacted with the inhibitor. Of these,
1 or 2 cysteine residues were classi¢ed as ‘fast-react-
ing’ and 3 or 4 cysteine residues as ‘slow-reacting’.
All substrates of the transhydrogenase accelerated
the rate of reaction of NBD chloride with the en-
zyme. Modi¢cation of the enzyme with NBD chlo-
ride resulted in inhibition, with the extent of inhibi-
tion being proportional to the degree of reaction of
the inhibitor with the enzyme.
With the expectation that NBD chloride might
provide some understanding of the role of sulfhydryl
groups in transhydrogenation, we have investigated
the reaction of NBD chloride with the pyridine nu-
cleotide transhydrogenase of E. coli. Several sites of
interaction of the inhibitor with the enzyme were
identi¢ed. Inhibition of non-mutant transhydroge-
nase was accompanied by modi¢cation of the two
cysteine residues of domain 2 of the L subunit. Cys-
teine-free mutant transhydrogenase was inhibited by
NBD chloride, indicating that residues other than
cysteine residues were modi¢ed by the inhibitor.
The residues were probably lysine residues on do-
mains 2 and 3 of the L subunit. The product derived
from the reaction of NBD chloride with NADPH
was an e¡ective inhibitor of transhydrogenase activ-
ity. Thus, NBD chloride is not useful as an inhibitor
of speci¢c sites on the transhydrogenase. The NBD-
NADPH adduct may be more useful for this pur-
pose.
2. Materials and methods
2.1. Bacterial strain, plasmids and mutagenesis
E. coli JM109 cells containing wild-type (pSA2) or
mutant plasmids were grown overnight at 37‡C in
LB broth. The medium was shaken at 250 rpm in a
New Brunswick Scienti¢c Controlled Environment
incubator shaker. Plasmid pSA2 contains the pnt
genes of the pyridine nucleotide transhydrogenase
of E. coli introduced into the pGEM-7Zf(+) plasmid
[7].
Plasmid pSA2 was used to isolate single-stranded
phagemid DNA. Site-directed mutagenesis to convert
selected residues was performed by the method of
Taylor et al. [21] using degenerate primers. The re-
agents and protocols as outlined in the Amersham
Sculptor and the Bio-Rad Muta-Gene phagemid in
vitro mutagenesis kits were followed, except that
competent E. coli JM109 cells were used for trans-
formation. Plasmid DNA was prepared from individ-
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ual colonies and the mutants were identi¢ed by dou-
ble-stranded DNA sequencing. The mutated region
was subcloned into non-mutated DNA and the mu-
tated region sequenced.
Plasmid pCH25, coding for a cysteine-free trans-
hydrogenase, was isolated as described in [22,23].
Plasmids pCH36 and pCH37 code for a cysteine-
free transhydrogenase in which the codons for
LCys-147 and LCys-260, respectively, have been re-
stored.
2.2. Preparation of Triton-washed inner membrane
vesicles containing transhydrogenase
The cell cultures were harvested by centrifugation
at 4400Ug for 20 min. The cell pellets were washed
by resuspension in 0.9% NaCl followed by centrifu-
gation at 12 000Ug for 15 min. Cell pellets were
resuspended in dithiothreitol (DTT)-free bu¡er A
(50 mM Tris-HCl, pH 7.8, 1 mM EDTA) [24] at
1 g wet weight/5 ml. All steps were performed at
0^4‡C. The cells were lysed by passage through an
Aminco French pressure cell at 1400 kg/cm2. Unbro-
ken cells were removed by centrifugation at
12 000Ug for 10 min. The supernatant was centri-
fuged at 252 000Ug for 2 h and the membrane pellet
containing everted membrane vesicles was suspended
in DTT-free bu¡er A at 1 g wet weight/5 ml. Mem-
brane vesicles (1.5 ml) were layered on a 6 ml sucrose
cushion (45% sucrose (w/w) in bu¡er A) and centri-
fuged in a Beckman Type 65 ¢xed angle rotor at
40 000 rpm (139 000Ug) for 1 h. The outer mem-
brane fraction pelleted to the bottom of the tube
and was discarded while the everted inner mem-
brane vesicles banded at the interface and were re-
moved by a syringe. The vesicles were diluted with
DTT-free bu¡er containing 1% (w/v) Triton X-100
and then centrifuged at 252 000Ug for 3 h. The
washed membrane pellet was suspended in 50 mM
4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid
(HEPES)-KOH, pH 8, 5 mM magnesium acetate
for use.
2.3. Puri¢cation of the transhydrogenases of pSA2
and pCH25
The crude membrane pellets, containing both inner
and outer membranes, from 10^12 g cells were pre-
pared as described in Section 2.2. The pellets were
suspended in bu¡er B (50 mM Tris-HCl, pH 7.8,
10% (v/v) glycerol, 1 mM EDTA, 1 mg/ml Brij-35)
and the transhydrogenases solubilized by stirring for
10 min with dodecyl maltoside at a concentration of
12.5 mg/ml. The mixture was centrifuged for 2.5 h at
252 000Ug. The supernatant was applied to a
DEAE-BioGel A column (17U2.5 cm) equilibrated
with bu¡er B. A linear gradient of 0^0.25 M NaCl in
bu¡er B (400 ml total volume) was applied. Frac-
tions containing the transhydrogenase were applied
to a column (115U2.5 cm) of Sepharose S-300 equil-
ibrated with bu¡er B. Active fractions eluted from
this column were stored individually at 365‡C.
2.4. Measurement of transhydrogenation activities
Transhydrogenation of 3-acetylpyridine adenine
dinucleotide (AcPyAD) by NADPH (‘reverse trans-
hydrogenation’) was measured as described previ-
ously [24]. An appropriate amount of puri¢ed en-
zyme or membrane was added to 1 ml of 50 mM
sodium phosphate bu¡er (pH 7), 0.5 mM EDTA,
2 mM DTT, 0.01% Brij-35 containing AcPyAD
and NADPH at 0.5 mM. Reduction of AcPyAD
was followed at 375 nm using a Perkin-Elmer Lamb-
da 3A UV/VIS spectrophotometer.
Transhydrogenation of AcPyAD by NADH in
the presence of NADP (‘cyclic transhydrogenation’)
was measured at pH 6.0 in a bu¡er containing 50 mM
2-(N-morpholino)ethane sulfonic acid (MES)-KOH,
0.5 mM EDTA, and 0.01% Brij-35. AcPyAD and
NADH were present at a concentration of 0.5 mM.
The concentration of NADP was 0.1 mM.
Protein concentrations were determined by the
method of Lowry et al. [25] or by using the BCA
(bicinchoninic acid) protein assay kit supplied by
Pierce (Rockford, IL, USA).
2.5. Reaction with NBD chloride
For most experiments puri¢ed transhydrogenases
from pSA2 or pCH25, or Triton X-100 washed inner
membrane vesicles, were incubated in the dark in 50
mM sodium phosphate bu¡er, pH 7.0, containing
0.5 mM EDTA and 0.01% Brij-35, with NBD chlo-
ride. For cyclic transhydrogenation the enzymes or
vesicles were incubated in the dark in 50 mM
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MES-NaOH bu¡er, pH 6.0, containing 0.5 mM
EDTA and 0.01% Brij-35, with NBD chloride.
The NBD-NADPH adduct was prepared by incu-
bating 0.4 Wmol NBD chloride with 0.5 Wmol
NADPH in 1 ml of 50 mM sodium phosphate bu¡er,
pH 7.0, containing 0.5 mM EDTA and 0.01% Brij-
35, for 24 h in the dark. No free NBD chloride could
be detected at this time and the absorption at 490
nm, indicative of amino group substitution by the
inhibitor, was at its maximum value. The maximum
contamination by free NADPH would be 20%.
2.6. Measurement of enzyme-bound NADPH
This measurement was carried out as described in
[26]
2.7. Sodium dodecyl sulfate-polyacrylamide gel
electrophoresis (SDS-PAGE)
SDS-polyacrylamide gel electrophoresis was car-
ried out by the Laemmli method [27]. Gels were
photographed under ultraviolet light before staining
with Coomassie blue.
2.8. Materials
All biochemicals including coenzymes and NBD
chloride were supplied by Sigma. DEAE BioGel A
and polyacrylamide solutions were obtained from
Bio-Rad. Sepharose S-300 and Sephadex G-50 were
purchased from Pharmacia. LB broth was supplied
by Difco.
3. Results
Most of the experiments in this study were carried
out using puri¢ed pyridine nucleotide transhydroge-
nases encoded by plasmids pSA2 [7] and pCH25
[22,23]. The transhydrogenase from pSA2 is the nor-
mal, non-mutant enzyme whereas that from pCH25
lacks the seven cysteine residues present in the nor-
mal enzyme. The mutations are KC292T, KC339T,
KC395S, KC397T, KC435S, LC147S and LC260S. In
some experiments inner membrane vesicles which
had been washed with a bu¡er containing Triton
X-100 were used. The transhydrogenase composes
at least 90% of the protein present in the vesicles.
3.1. E¡ect of NBD chloride on pyridine nucleotide
transhydrogenase activity
NBD chloride inhibited the reduction of
AcPyAD by NADPH (‘reverse transhydrogena-
tion’) by puri¢ed transhydrogenases from pSA2
Fig. 1. Inhibition of reverse transhydrogenase activities of puri¢ed enzymes from pSA2 and pCH25 by NBD chloride in the absence
and presence of pyridine nucleotide substrates. Transhydrogenase (pSA2, 0.15 mg protein/ml; pCH25, 0.37 mg protein/ml) was incu-
bated in the dark with 0.4 mM NBD chloride in the absence of pyridine nucleotides (E), or with 0.5 mM NADPH (W), NADP (a)
or NAD (O) present. Reverse transhydrogenase activity was assayed at the indicated time points. Activity is expressed as a percent-
age of the initial activity.
BBABIO 44790 27-10-99
P.D. Bragg, C. Hou / Biochimica et Biophysica Acta 1413 (1999) 159^171162
and pCH25 (Fig. 1). The cysteine-free enzyme from
pCH25 was less sensitive to inhibition. Substrates of
the enzyme a¡ected the rate of inhibition. NADPH
enhanced the rate of inhibition with both strains.
NAD provided some protection against the inhibi-
tion. Similar results were obtained using Triton X-
100 washed inner membrane vesicles. Addition of
DTT to the inhibited enzymes did not reverse inhibi-
tion.
The concentration dependency of inhibition of re-
verse and cyclic transhydrogenation in the presence
and absence of NADPH is shown in Fig. 2. In cyclic
transhydrogenation hydride equivalents from NADH
at the NAD(H) site on domain 1 are transferred via
bound NADP at the NADP(H) site of domain 3 to
AcPyAD now occupying the NAD(H) site. This
reaction is considered to measure hydride transfer
between the NAD(H) and NADP(H) sites in the ab-
sence of coupled proton translocation [28,29]. The
transhydrogenase from pCH25 was signi¢cantly less
sensitive than the enzyme from pSA2 to inhibition by
NBD chloride in both reverse and cyclic transhydro-
genation. In the presence of NADPH, which in-
creased the sensitivity of the enzymes to inhibition,
Fig. 2. E¡ect of concentration of NBD chloride on the inhibition of transhydrogenase activities in the absence or presence of 0.5 mM
NADPH. Puri¢ed transhydrogenases (A, 0.76 mg protein/ml; B, 0.83 mg protein/ml; C, 0.70 mg protein/ml; D, 0.83 mg protein/ml)
in the absence (E) or presence of 0.5 mM NADPH (W) were incubated with the indicated concentration of NBD chloride in the dark
for 2 h. The reaction was stopped by the addition of cysteine hydrochloride to a ¢nal concentration of 5.5 mM. Samples were ana-
lyzed for reverse (A and B) and cyclic (C and D) transhydrogenation. (A and C) pSA2; (B and D) pCH25. Activity is expressed as a
percentage of the activity in the absence of inhibitor.
BBABIO 44790 27-10-99
P.D. Bragg, C. Hou / Biochimica et Biophysica Acta 1413 (1999) 159^171 163
reverse transhydrogenation was inhibited 50% by
0.03 mM NBD chloride with the puri¢ed enzyme
from pSA2 compared with 0.3 mM for the transhy-
drogenase from pCH25.
3.2. Spectrophotometric examination of the reaction
of NBD chloride with pyridine nucleotide
transhydrogenases
Comparison of the inhibition of transhydrogena-
tion in the non-mutant and cysteine-free enzymes of
pSA2 and pCH25, respectively, suggested that the
increased inhibition of transhydrogenation in pSA2
was due to modi¢cation of cysteine residues. How-
ever, the sensitivity of the enzyme from pCH25 to
inhibition by NBD chloride clearly indicated that
other residues must be involved in inhibition. Puri-
¢ed transhydrogenases from pSA2 and pCH25 re-
acted with NBD chloride in the presence of
NADPH. The absorption spectra of the modi¢ed
enzymes were measured after removal of excess in-
hibitor on centrifuged columns of Sephadex G-50.
The modi¢ed enzyme from pSA2 had an absorption
band at 425 nm (Fig. 3). This band is characteristic
of the reaction of NBD chloride with the sulfhydryl
group of cysteine residues [13]. This band was not
visible in pCH25 and was most clearly seen in the
di¡erence spectrum between the inhibitor-modi¢ed
enzymes from pSA2 and pCH25 (Fig. 3). The ab-
sorption band at 425 nm was used to calculate the
extent of modi¢cation of the seven cysteine residues
which are present in the transhydrogenase from
pSA2. Using the extinction coe⁄cient determined
by Persson et al [20], a value of 2.15 þ 0.02 modi¢ed
cysteine residues/KL molecule was obtained.
Both of the modi¢ed enzymes from pSA2 and
pCH25 showed small absorption bands at 340 and
480 nm. The latter band was due to the reaction of
NBD chloride with amino groups [13,19]. Since
NADPH was present during reaction of NBD chlo-
ride with the inhibitor, the possibility that the 340 nm
band was due to the presence of this pyridine nucleo-
tide bound to the enzyme was examined. Nucleotide
analysis [26] showed that NADPH was absent.
3.3. Location of the modi¢ed groups in the
transhydrogenases from pSA2 and pCH25
Puri¢ed transhydrogenases from pSA2 and pCH25
were treated with NBD chloride in the presence and
absence of NADPH and then examined by electro-
phoresis on SDS-polyacrylamide gels. The presence
of bound NBD was shown by £uorescence under
ultraviolet light. As shown in Fig. 4A, the L subunit
was modi¢ed to a greater extent than the K subunit
in the enzymes of both strains. The presence of
NADPH during treatment with NBD chloride re-
duced the extent of modi¢cation of the L subunit
such that both K and L subunits were labeled to a
similar extent.
Trypsin in the presence of NADPH cleaves the K
and L subunits to yield well-recognized fragments
[30]. The K subunit is cleaved by trypsin to yield
initially a 43 kDa moiety which is essentially domain
1. This moiety is subsequently cleaved to give 29 and
16 kDa fragments. The L subunit is cleaved in the
presence of NADPH to yield 30 and 25 kDa frag-
ments. The 30 kDa fragment is essentially domain 3.
The 25 kDa fragment originates from the amino-ter-
minus of the L subunit and is part of domain 2. The
NBD-modi¢ed transhydrogenases from pSA2 and
pCH25 were treated with trypsin in the presence of
Fig. 3. Absorption spectra of puri¢ed transhydrogenases from
pSA2 and pCH25 treated with NBD chloride. The enzymes
(0.66 mg protein) in 1 ml of 50 mM sodium phosphate bu¡er,
pH 7.0, containing 0.5 mM EDTA, 0.01% Brij-35 and 0.5 mM
NADPH were treated with 0.5 mM NBD chloride in the dark
for 2 h. The samples were then passed through centrifuged 10
ml columns of Sephadex G-50 equilibrated with the same bu¡er
but without NADPH. Absorption spectra of the treated en-
zymes were measured in a SLM-Amino DW-2C spectrophotom-
eter. Spectrum a, pSA2; b, pCH25; c, measured di¡erence spec-
trum between pSA2 and pCH25; d, calculated di¡erence
spectrum between pSA2 and pCH25.
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NADPH (Fig. 4B). The 30 and 25 kDa fragments of
the L subunit were the most strongly labeled poly-
peptides seen under ultraviolet illumination. The 29
and 16 kDa polypeptides from the K subunit were
labeled to a lesser degree. Residual undigested L sub-
unit was also strongly £uorescent. The presence of
NADPH during labeling dramatically lowered the
labeling of the 30 kDa polypeptide. Since this poly-
peptide is essentially domain 3, which carries the
binding site for NADP(H), it is likely that NBD
chloride labeled a site close to this binding site and
that substrate protected against labeling. The en-
zymes from pSA2 and pCH25 behaved similarly in
these experiments, indicating that labeling of residues
other than cysteine residues had occurred. These are
most likely amino groups since NBD chloride yields
£uorescent products only with sulfhydryl and amino
groups. The phenolic hydroxyl group of tyrosine
does not yield a £uorescent product [13].
3.4. Location of modi¢ed cysteine residues in the
transhydrogenase from pSA2
The non-mutant transhydrogenase from pSA2
contains seven cysteine residues, ¢ve on the K sub-
unit and two on the L subunit [7,22,23]. The experi-
Fig. 5. E¡ect of NBD chloride on the reverse transhydrogenase
activities of Triton X-100 washed inner membrane vesicles from
pSA2 (curve a), pCH25 (curve b), pCH36 (curve c) and pCH37
(curve d). Membrane vesicles (0.43 mg protein/ml) were incu-
bated in the dark with 0.4 mM NBD chloride. Samples were
assayed for reverse transhydrogenase activity at timed intervals.
Activity is expressed as a percentage of the initial activity.
Fig. 4. SDS-PAGE of NBD chloride-treated puri¢ed transhy-
drogenases from pSA2 and pCH25. The gels on the left-hand
side were stained with Coomassie blue. On the right-hand side
are photographs of the same gels taken under ultraviolet light
before staining. (A) 1, untreated enzyme from pSA2; 2 and 3,
NBD chloride-treated enzyme from pSA2 treated in the absence
or presence of NADPH, respectively; 4, like 1, but with enzyme
from pCH25; 5 and 6, like 2 and 3 but with enzyme from
pCH25. (B) 1, untreated enzyme from pSA2; 2, untreated en-
zyme from pSA2 digested with trypsin in the presence of
NADPH; 3 and 4, enzyme from pSA2 treated with NBD chlo-
ride in the absence or presence of NADPH, respectively, and
then digested with trypsin in the presence of NADPH; 5, like
1, but with enzyme from pCH25; 6, like 2, but with enzyme
from pCH25; 7 and 8, like 3 and 4, but with enzyme from
pCH25. The enzymes were treated with 0.4 mM NBD chloride
in the dark for 1.5 h (A) and 2 h (B). The concentration of
acrylamide was 10% (w/v)(A) and 11% (w/v)(B). Trypsin diges-
tion was carried out as described in [30]. a and b denote K and
L subunits of the transhydrogenase. c and e denote the 30 and
25 kDa tryptic fragments of the L subunit. d and f denote 29
and 16 kDa tryptic fragments of the K subunit.
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ments described in the previous section (Section 3.3)
suggested that, in the presence of NADPH, the ma-
jor site(s) of modi¢cation by NBD chloride was in
the amino-terminal 25 kDa region of the L subunit.
This portion of domain 2 contains two cysteine res-
idues, LCys-147 and LCys-260. Triton X-100 washed
inner membrane vesicles were used to examine the
role of these residues in the sensitivity of the trans-
hydrogenase to inhibition by NBD chloride. Two
mutants were used. The transhydrogenase from
pCH36 contained only LCys-147, the remaining cys-
teines of the enzyme having been mutated to serine
or threonine residues. The enzyme from pCH37 was
similar except that LCys-260 was the only cysteine
residue. As shown in Fig. 5, the transhydrogenase
from pCH36 showed a sensitivity to NBD chloride
similar to that of pCH25 (cysteine-free), whereas the
enzyme from pCH37 more closely resembled the en-
zyme from pSA2 (non-mutant). Examination of the
absorption spectra of NBD chloride-treated Triton
X-100 washed inner membrane vesicles from
pCH36 and pCH37 revealed the band at 425 nM
characteristic of the product of the reaction of
NBD chloride with cysteine residues. Calculations
from the intensity of this band showed 0.98 and
0.57 mol cysteine/mol KL had been modi¢ed in the
transhydrogenases of pCH36 and pCH37, respec-
tively.
The above results indicate that modi¢cation of
LCys-260 by NBD chloride was responsible for the
inhibition of transhydrogenase activity.
3.5. E¡ect of other mutations on inhibition of
transhydrogenase activity
The e¡ect of NBD chloride on reverse transhydro-
genation with Triton X-100 washed inner membrane
vesicles of various mutants was studied. Since tyro-
sine residues are potential targets for the inhibitor,
we examined the enzymes with mutations KY226F/
LY315F/LY431F (conserved tyrosine residues in the
NAD(H) and NADP(H)-binding sites), or KY439F
and LY224F (the conserved tyrosine residues of do-
main 2). We also examined transhydrogenases con-
taining the conserved lysine residues KK228T
(NAD(H)-binding site) or LK145T (the only con-
served lysine residue of domain 2). Finally, as the
residues LHis-91, LAsp-213 and LAsn-222 have
been implicated in transmembrane proton pumping
by the transhydrogenase [31^33], we examined trans-
hydrogenases containing the mutations LH91N,
LD213N or LN222D.
None of the mutations described above provided
resistance to inhibition of reverse transhydrogenation
by NBD chloride (data not shown).
3.6. E¡ect of NBD chloride on the kinetics of
reduction of AcPyAD+ by NADPH (reverse
transhydrogenation)
Incubation of puri¢ed transhydrogenase or Triton
X-100 washed membrane vesicles with NBD chloride
in the presence of NADPH resulted in a lag in the
reduction of AcPyAD by NADPH before the ¢nal
Fig. 6. E¡ect of preincubation of NBD chloride-treated Triton
X-100 washed inner membrane vesicles from pCH25 with
AcPyAD or NADPH on the lag in the reverse transhydroge-
nase assay. Vesicles (0.64 mg protein/ml) were treated with 0.4
mM NBD chloride in the presence of 0.5 mM NADPH in the
dark for 75 min and then assayed for reverse transhydrogena-
tion. a, control - no inhibitor; b, NBD-treated; c, NBD-treated,
then preincubated with 0.5 mM NADPH for 5 min before the
assay of reverse transhydrogenation was started; d, same as c
but with the modi¢ed enzyme preincubated with 0.5 mM
AcPyAD. The change in absorption was measured at 375 nm.
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rate was attained. This is illustrated in Fig. 6 for X-
100 washed inner membrane vesicles from pCH25.
Preincubation of the inhibited enzyme with 0.5 mM
NADPH for 5 min before the assay was initiated by
addition of AcPyAD abolished the lag period. Pre-
incubation with 0.5 mM AcPyAD had no e¡ect. It
is concluded that NBD chloride modi¢cation in the
Fig. 7. Changes in the absorption spectrum with time of a mixture of NADPH and NBD chloride. NBD chloride (0.4 Wmol) and
NADPH (0.5 Wmol) were incubated in the dark in sodium phosphate bu¡er, pH 7.0, containing 0.5 mM EDTA and 0.01% Brij-35.
The absorption spectrum was measured at timed intervals in a SLM-Aminco DW-2C spectrophotometer. 1, NADPH alone; 2, NBD
chloride alone; 3^9, spectra of the mixture at 0, 0.5, 1, 2, 3, 5 and 7 h.
Fig. 8. Inhibition by the NBD-NADPH adduct of the transhydrogenase activities of puri¢ed enzymes from pSA2 and pCH25. (A)
The transhydrogenases from pSA2 (E) and pCH25 (W) were preincubated in the dark for the indicated time with 18.2 WM NBD-
NADPH adduct before assay for reverse transhydrogenase activity. (B) The transhydrogenases from pSA2 (E,a) and pCH25 (W)
were preincubated in the dark for 30 min with the indicated concentration of the NBD-NADPH adduct before assay for reverse
(E,W) and cyclic (a) transhydrogenase activities.
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presence of NADPH a¡ected the ease of binding of
NADPH to the enzyme.
3.7. Formation of a transhydrogenase inhibitor by
reaction of NBD chloride with NADPH
The most e¡ective inhibition of transhydrogenase
activity occurred when the enzyme was modi¢ed with
NBD chloride in the presence of NADPH. This was
unexpected since, as shown above, NADPH pro-
tected against modi¢cation of the L subunit by the
reagent. We considered the possibility that NBD
chloride reacted with the amino group of NADPH
to generate an inhibitor. Fig. 7 shows the changes in
the absorption spectrum with time of a mixture of
NADPH and NBD chloride. NADPH and NBD
chloride together showed an absorption maximum
at 340^345 nm. With time this shifted towards lower
wavelengths. A new absorption band developed at
about 470 nm. The reaction of amino groups with
NBD chloride produces an absorption band at 475
nm [13]. Thus, it is likely that the 470 nm absorption
band was due to reaction of the amino group of the
adenine moiety of NADPH with NBD chloride.
The ability of the compound (NBD-NADPH)
formed by the reaction of NBD chloride with
NADPH to act as an inhibitor of the transhydroge-
nase was examined. NBD-NADPH was e¡ective in
inhibiting the reverse transhydrogenase activities of
the puri¢ed enzymes from pSA2 and pCH25 (Fig.
8A). NBD-NAD(H) adducts were not inhibitory.
Half-maximal inhibition of reverse transhydrogena-
tion with pSA2 and pCH25 was given by 7 and 4 WM
NBD-NADPH, respectively (Fig. 8B). Cyclic trans-
hydrogenation of AcPyAD by NADH was also
e¡ectively inhibited (Fig. 8B). NBD-NADPH was
not competitive with NADPH for a binding site
on the transhydrogenases from pSA2 and pCH25
(Fig. 9).
4. Discussion
The only previous study of the reaction of NBD
chloride with a pyridine nucleotide transhydrogenase
is that of Persson et al. [20] with the enzyme from
beef-heart mitochondria. They found that the trans-
hydrogenase was labeled by NBD chloride in a bi-
phasic reaction with 1 or 2 cysteine residues being
labeled rapidly and 3 or 4 residues more slowly. La-
beling was accompanied by inhibition of transhydro-
genation. All substrates of the enzyme enhanced the
rate of inhibition. On irradiation with ultraviolet
light at 366 nm transfer of NBD from sulfhydryl to
Fig. 9. E¡ect of the NBD-NADPH adduct on reverse transhydrogenase activities of puri¢ed enzymes from pSA2 (7.4 Wg protein) (A)
and pCH25 (46 Wg protein) (B). E, no adduct; W, preincubated in dark for 30 min with 10.9 WM NBD-NADPH adduct before assay.
The reverse transhydrogenase activities were assayed at di¡erent concentrations of NADPH. The concentration of AcPyAD was 0.5
mM. v is expressed in nmol/min.
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amino groups was observed. These workers proposed
that NBD chloride reacted with sulfhydryl groups
which were not at the active sites of the enzyme
but which were conformationally linked to them.
The speci¢c cysteine residues labeled by the inhibitor
were not determined.
The present study has extended this work and in-
dicated that NBD chloride has several targets for
interaction with the pyridine nucleotide transhydro-
genase of E. coli. Cysteine residues were not the only
amino acid residues modi¢ed by NBD chloride. The
absorption spectrum of the modi¢ed enzyme showed
the absorption band at about 480 nm which is char-
acteristic of the reaction of amino groups with NBD
chloride [13]. Moreover, the cysteine-free enzyme
from pCH25 was inhibited by NBD chloride. Both
K and L subunits reacted with NBD chloride. The K
subunit was less modi¢ed than the L subunit. The
tryptic cleavage pattern of the enzyme indicated
that domain 1 in the K subunit was labeled. Labeling
occurred in at least two regions of domain 1 since
both tryptic cleavage fragments (29 and 16 kDa),
resulting from scission of domain 1 at KLys-228,
were labeled to some degree by the reagent. The L
subunit was labeled strongly by NBD chloride in
both the amino-terminal domain 2 (25 kDa tryptic
fragment) and carboxyl-terminal domain 3 (30 kDa
tryptic fragment) regions.
The transhydrogenase activities of the enzyme
from non-mutant pSA2 were more sensitive to inhi-
bition by NBD chloride than those of the cysteine-
free enzyme from pCH25. The enzyme from pSA2
reacted with NBD chloride with modi¢cation of only
two of the seven cysteine residues present in the
transhydrogenase. Therefore, it is likely that modi¢-
cation of these two cysteine residues is associated
with the increased sensitivity of the enzyme from
pSA2 to the inhibition by NBD chloride. Experi-
ments with mutant enzymes from pCH36 and
pCH37 indicated that the two labeled cysteines in
the transhydrogenase of pSA2 were probably LCys-
147 and LCys-260. LCys-147 is located in a cytosolic
loop between two transmembrane K-helices. LCys-
260 is at the cytosolic end of a transmembrane K-
helix [33]. LCys-147 is in a more exposed position
than LCys-260. It reacts with the polar sulfhydryl-
reacting biotin maleimide whereas LCys-260 does
not react [34]. However, LCys-260 reacts with the
non-polar N-(1-pyrenyl) maleimide with inhibition
of transhydrogenase activity [23]. Thus, the inhibi-
tion produced by the reaction of LCys-260 with
NBD chloride is analogous to that produced by N-
(1-pyrenyl) maleimide. This cysteine residue is con-
served in all known transhydrogenase sequences. It is
equivalent to Cys-834 of the beef-heart mitochon-
drial enzyme [35]. Given the structural similarity of
the transhydrogenases, it is likely that this residue
was one of the 1 or 2 fast-reacting cysteine residues
observed by Persson et al. [20].
A second region of modi¢cation by NBD chloride
was domain 3 of the L subunit (30 kDa tryptic frag-
ment). Modi¢cation here was prevented by NADPH.
Since the presence of NADPH accelerates the inhib-
itory e¡ect of NBD chloride, it is unlikely that mod-
i¢cation of domain 3 is associated with inhibition of
transhydrogenase activity. The protective e¡ect of
NADPH against modi¢cation of domain 3 by
NBD chloride does not necessarily indicate that
NBD chloride reacts at the NADPH-binding site.
Binding of NADPH induces a conformational
change in the L subunit as re£ected in an increased
susceptibility to proteolysis [30]. Therefore, the pro-
tective e¡ects of NADPH may be indirect. However,
reaction with NBD chloride in the presence of
NADPH did a¡ect the binding of this substrate to
the modi¢ed enzyme. This was indicated during the
assay of transhydrogenase activity by the induction
of a lag period before maximum rates were attained.
The lag was overcome by preincubation of the modi-
¢ed enzyme with NADPH. Since the enzyme had
reacted with NBD chloride in the presence of
NADPH, it is likely that the e¡ect of modi¢cation
on the binding of NADPH to its binding site in
domain 3 was associated with the modi¢cation of
residues in the amino-terminal domain 2 region (25
kDa tryptic fragment) of the L subunit. An analo-
gous e¡ect has been observed previously in mutants
of the proton translocation pathway of the transhy-
drogenase. Residues LHis-91, LAsp-213 and LAsn-
222 are located in the 25 kDa region. Mutation of
these residues a¡ected binding of NADP(H)
[26,32,33] but did not provide resistance to inhibition
by NBD chloride. The site(s) of interaction of NBD
chloride in the 25 kDa region has not been identi¢ed.
The spectrophotometric data suggest that it is likely
to be an amino group(s). Mutation of the only con-
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served lysine residue in this region, LLys-145, did not
provide resistance to inhibition by NBD chloride
(data not shown).
A third inhibitory e¡ect of NBD chloride occurred
when the enzyme was incubated with the inhibitor in
the presence of NADPH. NBD chloride formed an
adduct with the pyridine nucleotide. The NBD-
NADPH adduct inhibited both reverse and cyclic
transhydrogenation activities. Half-maximal inhibi-
tion was obtained with concentrations of the NBD-
NADPH adduct less than 10WM. The NBD-NADPH
adduct was not competitive with NADPH suggesting
that the adduct was not reacting directly with the
NADP(H)-binding site on domain 3. On the other
hand, the lack of inhibition by NBD-NAD(H) ad-
ducts favors speci¢c interaction of the NBD-
NADPH adduct at the NADP(H)-binding site. It is
di⁄cult to explain these con£icting data. One possi-
ble explanation is that the NBD-NADPH adduct
binds to the NADP(H)-binding site through its
NADPH moiety but it also interacts with an adjacent
non-polar site through its NBD moiety. If the latter
interaction is su⁄cient to yield an inhibited enzyme,
the displacement of the NADPH moiety by com-
peting NADPH would not yield a fully reactivated
enzyme. As might be expected from the structure
of the adduct, there was no indication that the en-
zyme was covalently labelled by the inhibitor. The K
and L subunits were not £uorescent following SDS-
polyacrylamide gel electrophoresis of transhydroge-
nase which had been incubated for 2 h with the ad-
duct.
In summary, the e¡ect of NBD chloride on the
pyridine nucleotide transhydrogenase of E. coli was
complex. Reaction of this compound with LCys-260
inhibited the enzyme. In addition non-cysteine resi-
dues, probably lysine residues, in K and L subunits
reacted with the inhibitor. Modi¢cation of domain 3
did not result in inhibition and was prevented by
NADPH. Inhibition was produced by modi¢cation
of the amino-terminal domain 2 region of the L sub-
unit. This a¡ected binding of NADPH to its binding
site on domain 3. In addition, the NBD-NADPH
adduct was a potent inhibitor of transhydrogenation.
Thus, in experiments with NBD chloride in the pres-
ence of NADPH all of these sites of reaction will
contribute to the inhibition observed. It is likely
that the NBD-NADPH adduct will be more useful
than NBD chloride in investigations of the pyridine
nucleotide transhydrogenase.
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